Doc Code: TRACK1 .REQ
`Document Description: TrackOne Request
`
`PTOJAIA/424 (04- 14}
`
`CERTIFICATION AND REQUEST FOR PRIORITIZED EXAMINATION
`UNDER 37 CFR 1.102(e) (Page 1 of 1)
`
`First Named
`Inventor:
`Tille of
`Invention:
`
`de Palo, Francesco
`
`known):
`STABLE, CONCENTRATED RADIONUCLIDE COMPLEX SOLUTIONS
`
`I Non provisional Application Number (if I
`
`APPLICANT HEREBY CERTIFIES THE FOLLOWING AND REQUESTS PRIORITIZED EXAMINATION FOR
`THE ABOVE-IDENTIFIED APPLICATION.
`
`1. The processing fee set forth in 37 CFR 1.17(i)(1) and the prioritized examination fee setforth in
`37 CFR 1.17(c) have been filed with the request. The publication fee requirement is met
`because that fee, set forth in 37 CFR 1.18(d) , is currently $0. The basic filing fee , search fee,
`and examination fee are filed with the request or have been already been paid. I understand
`that any required excess claims fees or application size fee must be paid for the application .
`
`2. I understand that the application may not contain, or be amended to contain, more than four
`independent claims, more than thirty total claims, or any multiple dependent claims, and that
`any request for an extension of time will cause an outstanding Track I request to be dismissed.
`
`i.
`
`3. The applicable bo.x is checked below;
`I. Fl Original Application {Track One) - Prioritized Examination under§ 1.102(e)(1)
`(a) The application is an original nonprovisional utility application fi led under 35 U.S.C. 111(a).
`This certification and request is being filed with the utility application via EFS-Web.
`--OR--
`(b) The application is an original nonprovislonal plant application filed under 35 U.S.C. 111(a).
`This certification and request is being filed with the plant application in paper.
`
`ii. An executed inventor's oath or declaration under 37 CFR 1.63 or 37 CFR 1.64 for each
`inventor, Q! the application data sheet meeting the conditions specified in 37 CFR 1.53(f}(3)(i) is
`filed with the application.
`II. 0 Request for Continued Examination - Prioritized Examination under§ 1.102(e)(2)
`i. A request for continued examination has been filed with , or prior to, this form.
`If the application is a utility application, this certification and request is being filed via EFS-Web.
`ii.
`iii. The application is an original nonprovisional utility application fi led under 35 U.S.C. 111 (a) , or is
`a national stage entry under 35 U.S.C. 371 .
`iv. This certification and request is being filed prior to the mailing of a first Office action responsive
`to the request for continued examination.
`v. No prior request for continued examination has been granted prioritized examination status
`under 37 CFR 1.102(e)(2).
`
`Sianature /Lian Ouyang/
`~ ri~~vped) Lian Ouyang
`Note: T/Jis form must be signed 1n accordance wit/J 37 CFR 1.33. See 37 CFR 1.4(d) for signature requirements and certificatfons.
`Submit multi1Jle forms if more t/1an one sianature is reauired. •
`
`Oa!e 10/30/2018
`69 254
`
`Practitioner
`Reaistrafion Number
`
`l
`
`0 ·Total of 1
`
`forms are submitted .
`
`Evergeen Ex. 1004
`1 of 324
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 (P .L. 93-579) requires that you be given certain information ln connection with your
`submission of the attached form related to a patent application or patent. Accordingly, pursuant to the requirements of
`the Act, please be advised that: (1) the general authonty for the collection of this information is 35 U.S.C. 2(b)(2); (2)
`furnishing of the information solicited is voluntary; and (3) the principal purpose ·for Which the information is used by the
`U.S. Patent and Trademark Office is to process and/or examine your submisslon related to a patent application or
`patent. If you do not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
`process and/or examine your submission , which may result in termination of proceedings or abandonment of the
`application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1. The information on this form will be treated confidentially to the extent allowed under the Freedom of
`Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of records may
`be disclosed to the Department of Justice to determine whether disclosure of these records is required by the
`Freedom of Information Act.
`2. A record from this system of records may be discfosed, as a routine use, m the course of presenting evidence
`to a court, magistrate, or administrative tribunal. including disclosures to opposing counsel in the course of
`settlement negotiations.
`3. A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an indTvldual, to whom the record pertains, when the indlvldual has requested assistance from
`the Member with respect to the subject matter of the record.
`4. A record in this system of records may be disclosed, as a routine use, t,o a contractor of the Agency having
`need for the information in order to perform a contract. Recipients of information shall be required to comply
`with the requirements of the Privacy Act of 1974, as amended, pursuant to s u.s.c. 552a(m).
`5. A record related to an International Application filed under the Patent Cooperation Treaty in this system of
`records may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property
`Organization, pursuant to the Patent Cooperation Treaty.
`6. A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes
`of National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C.
`218(c)).
`7. A record from this system of records may be disclosed, as a routine use, to the Administrator, General
`Services, or his/her designee, during an inspection of records conducted by GSA as part of that agency's
`responsibility to recommend improvements in records management practices and programs, under authority of
`44 U.s.c. 2904 and 2906. Such disclosure shall be made in accordance with the GSA regulations governing
`inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such
`disclosure shall not be usect· to make determinations about individuals.
`8. A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151 . Further, a
`record may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record
`was filed in an application which became abandoned or in which the proceedings were terminated and which
`application is referenced by either a published applfcation, an application open to public Inspection or an issued
`patent.
`9. A record from this system of records may be disclosed, as a routine use, to a Federal. State, or local law
`enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.
`
`Evergeen Ex. 1004
`2 of 324
`
`

`

`PTO/AW14 (1M5)
`Approved for use through 04130l2017. 0MB 0651 ·0032
`U .S . Paten! and Trademark Office; lJ.S , OEPARTIAENT OF COMMERCE
`Underlhe Pli!)e!Work Reduction Act of 1995, no persons are required lo resp1111d lo a collectlon of infO{Tilallon unless It contains a valkl 0MB control number.
`
`Application Data Sheet 37 CFR 1. 76
`
`Attorney Docket Number
`
`PAT058197-US-CNT02
`
`Application Number
`
`ntle of Invention
`
`Stable, concentrated radionuclide complex solutions
`
`The application data sheet is part of the provisional or nonprovisional application for which It is being submitted. The following rorm conCa,ns lhe
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as ot.rllined in 37 CFR 1.76.
`This document may be completed electronic.ally and submitted ID the Office in electronic format using the Electronic Filing System (EFS) or the
`document may be printed and included fn a paper filed application.
`
`Secrecy Order 37 CFR 5.2:
`D Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuant to
`37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may not be filed electronically.)
`
`Inventor Information:
`
`Inventor
`11
`Legal Name
`
`I Remove I
`
`Prefix Given Name
`
`Middle Name
`
`Family Name
`
`I I· trancesco
`
`Residence Information (Select One)
`
`City
`
`~olleretto Giacosa
`
`US Residency
`
`I
`• Non US Residency
`II Country of Residence i
`
`~ePalo
`
`Active US Military Service
`1[!
`
`Mailing Address of Inventor:
`
`Address 1
`
`~,o Advanced Accelerator Applications (Italy) Sri
`
`Via Ribes. 5
`
`Address 2
`I p11eretto Giacosa
`City
`1110010
`Postal Code
`Inventor ~
`Legal Name
`
`Prefix Given Name
`
`I l· ~orenza
`
`Residence Information (Select One)
`
`City
`
`~olleretto Giacosa
`
`I State/Province
`I ~T
`I Countryi
`
`11
`
`I Remove I
`
`Middle Name
`
`Family Name
`I
`l=ugazza
`US Residency @ Non US Residency
`Ii country of Residence i
`
`-
`
`-
`
`Active US Military Service
`1(E
`
`Suffix
`I·
`I
`I
`
`Suffix
`I·
`I
`
`I
`
`Mailing Address of Inventor:
`
`Address 1
`
`:lo Advanced Accelerator Applications (Italy} Sri
`
`Address 2
`I f:olletetto Giacosa
`City
`1110010
`Postal Code
`
`Via Ribes, 5
`
`Inventor 6
`
`Legal Name
`
`EFS Web 2.2.12
`
`I State/Province
`I rr
`I Country i
`
`11
`
`I Remove I
`
`Evergeen Ex. 1004
`3 of 324
`
`

`

`PTO/AW14 (11-15)
`Approved for use through 0413012017. 0MB 0651 ·0032
`U .S . Patent and Trademark Office; U.S OEPARn.lENT OF COMMERCE
`Under the Par,erwork Reduclion Act or 1995, no persons are required lo respond lo a collec1ion af infomialion unless it contains a vaud 0MB control number.
`
`Appljcation Data Sheet 37 CFR 1. 76
`
`Attorney Docket Number
`
`PAT058197-US-CNT02
`
`,Application Number
`
`Title of Invention
`
`Stable, concentrated radionuclide complex solutions
`
`Prefix Given Name
`
`Middle Name
`
`Family Name
`
`I El IJonato
`
`Residence Information (Select One)
`
`City
`
`~o lleretto Giacosa
`
`I
`'3arbato
`US Residency @ Non US Residency
`II Country of Residence i
`
`Active US Military Service
`
`1lr
`
`I
`
`SOfFrx
`El
`I
`
`Mailing Address of Inventor:
`
`Address 1
`
`:lo Advanced Accelerator Applications (Italy) Sri
`
`Via Ribes, 5
`
`Address 2
`I ~olleretto Giacosa
`City
`1110010
`Postal Code
`Inventor ~
`Legal Name
`
`Prefix Given Name
`I I· ~aulizio
`Residence Information (Select One)
`
`City
`
`~olleretto Giacosa
`
`I State/Province
`I ~T
`I Countryi
`
`11
`
`I Remove I
`
`Family Name
`
`Middle Name
`I
`,-..,ariani
`US Residency @ Non US Residency
`Ii country of Residence i
`
`Active US Military Service
`
`1lr
`
`Mailing Address of Inventor:
`
`Address 1
`
`,;lo Advanced Accelerator Applications (Italy) Sri
`
`Via Ribes, 5
`
`Address 2
`City
`Postal Code
`
`Legal Name
`
`I JAlleretto Giacosa
`1110010
`Inventor b
`
`I State/Province
`I ~T
`I Country i
`
`11
`
`I Remove I
`
`Prefix Given Name
`I El fJaniela
`Residence Information (Select One)
`ta lleretto Giacosa
`
`City
`
`Middle Name
`I
`f;:hicco
`US Residency @ Non US Residency
`II Country of Residence i
`
`family Name
`
`Active US Military Service
`
`11!
`
`Mailing Address of Inventor:
`
`Address 1
`
`';Jo Advanced Accelerator Applications (Italy) Sri
`
`Address 2
`City
`Postal Code
`
`I ~olleretto Giacosa
`1110010
`
`Via Ribes, 5
`
`EFS Web 2.2-12
`
`I 'State/Province
`I ~T
`I Country i
`
`11
`
`Suffix
`1~
`I
`
`I
`
`Suffix
`I El
`I
`
`Evergeen Ex. 1004
`4 of 324
`
`

`

`PTO/AWM (11-15)
`Approved for use through 04130/-2017. 0MB 0651 ·0032
`U .S . Patent and T rademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Redud ion Act of 1995, no persons are required lo respond lo a collec1ion af infonnalion unless it oonlains a vaud 0MB control number.
`
`Appljcation Data Sheet 37 CFR 1. 76
`
`Attorney Docket Number
`
`PAT058197-US-CNT02
`
`-Application Number
`
`Title of Invention
`
`Stable, concentrated radionuclide complex solutions
`
`Inventor ~
`Legal Name
`
`Prefix Given Name
`
`I I· '3iovanni
`
`Residence Information (Select One}
`
`City
`
`~olleretto Giacosa
`
`Mailing Address of Inventor:
`
`I Remove I
`
`Middle Name
`
`l=amily Name
`If esoriere
`I
`US Residency @ Non US Residency
`II Country of Residence 1
`
`Active US Military Service
`11!
`
`Address 1
`
`~,o Advanced Accelerator Applica1ions (Italy) Sri
`
`Via Ribes, 5
`Address 2
`I toneretto Giacosa
`I State/Province
`City
`I rr
`1110010
`I Count ry i
`Postal Code
`All Inventors Must Be Listed • Additional Inventor Information blocks may be
`generated within th s form by selecting the Add button.
`
`11
`
`I
`
`Add
`
`I
`
`Correspondence Information:
`Enter either Customer Number or complete the Correspondence Information section below.
`For further information see 37 CFR 1.33(a).
`D An Address is being provided for the correspondence Information of this application.
`) 1095
`Customer Number
`
`Suffix
`I·
`I
`I
`
`•
`
`Email Address
`
`pip_inbox.phchbs@novartis.com
`
`Application Information:
`
`I I Add Eroan I
`
`I Remove Email I
`
`Title of the Invention
`
`Stable, concentrated radionuclide complex solutions
`
`Attorney Docket Number PAT058197-US-CNT02
`
`I Small Entity Status Claimed
`
`(cid:143)
`
`...
`
`9
`
`I Suggested Figure for Publication (if any) 11
`
`Application Type
`
`Nonprovis1onal
`
`Subject Matter
`
`Utility
`
`Total Number of Drawing Sheets (if any)
`
`Ir
`
`EFS Web 2.2-12
`
`Evergeen Ex. 1004
`5 of 324
`
`

`

`PTO/AWM (11-15)
`Approved for use through 04130/2017. 0MB 0651 ·0032
`U .S. Patent and Trademark Office; U.S , DEPARTMENT OF COMMERCE
`Under the Paperwork Redud ion Act or 1995, no persons are required to respond lo a collec1ion of infO£TTiaoon unless it oontains a valid 0MB control number.
`
`Application Data Sheet 37 CFR 1. 76
`
`Attorney Docket Number
`
`PAT058197-US-CNT02
`
`Application Number
`
`Title of Invention
`
`Stable, concentrated radionuclide complex solutions
`
`Filing By Reference:
`Only complete this section when filing an application by reference under 35 U.S.C. 111 (c) and 37 CFR 1.57(a). Do not complete this section if
`application papers including a specification and any drawings are being filed . Any domestic benefit or foreign priority information must be
`provided in the appropriate section(s) below (i.e ., •oomestic Benefit/National Stage Information a and "Foreign Priority Information").
`
`For the purposes of a filing date under 37 CFR 1.53(b), the description and any drawings of the present application are replaced by this
`refe rence to the previously filed application, subject to conditions and requirements of 37 CFR l57(a).
`Filing date (VYYY-MM-DD)
`
`lntellectua'I Property Authority or Country
`
`Application number of the previously
`filed application
`
`1 1
`
`11
`
`I
`Publication Information:
`D Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`Request Not to Publish. I hereby request that the attached application not be published under
`35 U.S.C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`subject of an application filed in another country, or under a multilateral international agreement. that requires
`publication at eighteen months after filing .
`
`(cid:143)
`
`,-
`
`I
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Applfcation Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below. If both sections are completed the customer
`Number will be used (or the Representative Information during processing.
`
`Please Select One:
`
`• Customer Number
`
`I
`
`US Patent Practitioner 10 Limfted Recognition (37 CFR 11.9)
`
`Customer Number
`
`~ -1095
`
`Domestic Benefit/National Stage Information:
`This secfion allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) or indicate
`National Stage entry from a PCT application. Providing benefit claim fnformation in the Application Data Sheet constitutes
`the specific reference required by 35 U.S.C. 119(e) or 120, and 37 CFR 1. 78.
`When referring to the current application. please leave the "Application Number" field blank.
`ly
`
`Prior Application Status
`
`tending
`
`I Remove I
`Filing or 371(c) Date
`(YYYY-MM-DD)
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`J:;ontinuation of
`
`1~ 16/140962
`
`~018-09-25
`
`I
`
`EFS Web 2.2.12
`
`Evergeen Ex. 1004
`6 of 324
`
`

`

`PTO/AWM (11-15)
`Approved for use through 04130/2017. 0MB 0651 ·0032
`U .S . Patent and Trademarl< Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Redudion Act or 1995, no persons are required to respond lo a collection of infonnalion unless it oonlains a valid 0MB control number.
`
`Application Data Sheet 37 CFR 1. 76
`
`Attorney Docket Number
`
`PAT058197-US-CNT02
`
`-Application Number
`
`Title of Invention
`
`Stable, concentrated radionuclide complex solutions
`
`Prior Application Status
`
`t'endfng
`
`1~
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`I Remove I
`Filing or 371(c) Date
`(YYYY-MM-0D)
`
`~6/140962
`
`tontinuation in part of
`
`I· 16/045484
`
`Additional Domestic Benefit/National Stage Data may be generated within this form
`by selecting the Add button .
`
`po1a-01-25
`I Add
`
`I
`
`Foreign Priority Information:
`
`This section allows for the applicant to claim priority to a foreign application. Providing this information in the application data sheet
`constitutes the claim for priority as required by 35 U.S.C. 119(b) and 37 CFR 1.5_5. When priority is claimed to a foreign application
`that is eligible for retrieval under the priority document exchange program (PDX)1 the information will be used by the Office to
`automatically attempt retrieval pursuant to 37 CFR 1.55(.i){ 1) and (2). Under the PDX program, applicant bears the ultimate
`responsibility for ensuring that a oopy of the foreign application is rec:eived by the Offic:e from the participating foreign intellectual
`property office, or a certified copy of the foreign priority application is filed, within the time period specified in 37 CFR 1.55(g){ 1 ).
`
`Application Number
`
`Countryi
`
`Filing Date (YYYY-MM-DD)
`
`Access CodJ (if applicable)
`
`i=>CT/1B2018/057415
`
`1No
`
`~018-09-25
`
`Application Number
`
`Countryi
`
`Filing Date (YYYY-MM-0D)
`
`J:>CT/1B2018/055575
`
`1No
`~018-07-25
`Additional foreign Priority Data may be generated within this form by selecting the
`Add button.
`
`I Remove I
`Access Codei (if applicable)
`
`I Add I
`
`·1 Remove I
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition
`Applications
`
`This application (1) claims priority to or the benefit of an application fifed before March 16, 2013 and (2) also
`contains, or contained at any time, a claim to a claimed invention that has an effective filing date on or after March
`0 16, 2013.
`NOTE: By providing this statement under 37 CFR 1.55 or 1.78, this application, with a filing date on or after March
`16, 2013, will be examined under the first inventor to file provisions of the AIA
`
`EFS Web 2.2-12
`
`Evergeen Ex. 1004
`7 of 324
`
`

`

`PTO/AW14 (11-15)
`Approved for use through 04/30/-2017. 0MB 0651 ·0032
`U .S . Patent and Trademark Office; U.S, DEPARTMENT OF COMMERCE
`Under the Paperwork Redudion Act or 1995, no persons are required to respond lo a collection of infoonaoon unless it contains a valid 0MB control number.
`
`Application Data Sheet 37 CFR 1. 76
`
`Attorney Docket Number
`
`PAT058197-US-CNT02
`
`Application Number
`
`Title of Invention
`
`Stable, concentrated radionuclide complex solutions
`
`Authorization or Opt-Out of Authorization to Permit Access:
`
`When this Application Data Sheet is properly signed and filed with the application , applicant has provided written
`authority to permit a participating foreign intellectual property (IP) office access to the instant application-as-filed (see
`paragraph A in subsection 1 below) and the European Patent Office (EPO) access to any search results from the instant
`application (see paragraph B -in subsection 1 below).
`
`Should applicant choose not to provide an authorization identified in subsection 1 below, applicant must opt-out of the
`authorization by checking the corresponding box A or B or both in subsection 2 below.
`
`HQIE: This section of the Application Data Sheet is ONLY reviewed and processed with the INITIAL filing of an
`application. After the initial filing of an application, an Application Data Sheet cannot be used to provide or rescind
`authorization for access by a foreign IP office(s). Instead, Form PTO/SB/39 or PTO/SB/69 must be used as appropriate.
`
`1. Authorization to Permit Access by a Foreign Intellectual Property Office(s)
`
`A. Priority Document Exchange (POX) - Unless box A in subsection 2 (opt-out of authorization) is checked, the
`undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO), the Japan Patent Office
`(JPO), the Korean Intellectual Property Office (KIPO), the State Intellectual Property Office of the People's Republic of
`China (SIPO), the World Intellectual Property Organization (WIPO), and any other foreign intellectual property office
`participating With the USPTO in a bilateral or multilateral priority document exchange agreement in Which a foreign
`application claiming priority to the instant patent application is filed, access to: (1) the instant patent application-as-filed
`and its related bibliographic data. (2) any foreign or domestic application to which priority or benefit is claimed by the
`instant application and its related bibliographic data, and (3) the date of filing of this Authorization. See 37 CFR 1.14(h)
`(1 ).
`
`B. Search Results from U.S. Application to EPO - Unless box B in subsection 2 (opt-out of authorization) is checked,
`the undersigned hereby grants the USPTO authority to provide the EPO access to the bibliographic data and search
`results from the instant patent application when a European patent application claiming priority to the instant patent
`application is filed. See 37 CFR 1.14(h)(2).
`
`The applicant is reminded that the EPO's Rule 141 (1) EPC (European Patent Convention) requires applicants to submit a
`copy of search results from the instant application without delay in a European patent application that claims priority to
`the instant application.
`
`2. Opt-Out of Authorizations to Permit Access by a Foreign Intellectual Property Office(s)
`
`A. Applicant DOES NOT authorize the USPTO to permit a participating foreign IP office access to the instant
`D application-as-filed . If this box is checked, the USPTO will not be providing a participating foreign IP office with
`any documents and information identified in subsection 1A above.
`
`8. Applicant DOES NOT authorize the USPTO to transmit to the EPO any search results from the instant patent
`D application . If this box is checked, the USPTO will not be providing the EPO with search results from the instant
`application.
`NOTE: Once the application has published or is otherwise publicly available, the USPTO may provide access to the
`application in accordance with 37 CFR 1.14.
`
`EFS Web 2.2.12
`
`Evergeen Ex. 1004
`8 of 324
`
`

`

`PTO/AW14 (11-15)
`Approved for use through 04130/2017. 0MB 0651 ·0032
`U .S . Patent and Trademark Office; U.S , DEPARTMENT OF COMMERCE
`Under the Paperwork Redudion Act of 1995, no persons are required to respond lo a collec1ion of infonnaoon unless it oonlains a vaud 0MB control number.
`
`Application Data Sheet 37 CFR 1. 76
`
`Attorney Docket Number
`
`PAT058197-US-CNT02
`
`,Application Number
`
`Title of Invention
`
`Stable, concentrated radionuclide complex solutions
`
`Applicant Information:
`
`Providing assignment information in this section does not substitute for compliance with any requirement of part 3 of TIiie 37 of CFR
`to have an assignment recorde<I by the Office.
`
`If the applicant is the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The information to be provided in this section is the name and address of the legal representative who is the applicant under 37 CFR
`1.43; or the name and address of the assignee, person to whom the inventor is under an obligation to assign the invention, or person
`Who otherwise shows sufficient proprietary interest in ttie matter who is the applicant un(ler 37 CFR 1 -46. If the applicant is an
`applicant under 37 CFR 1.46 {assignee, person to Whom the inventor is obligated to assign, or person who otherwise shows sufficient
`proprietary ihlerest) together with one or more joint inventors, then the joint inventor or Inventors who are also the applicant should be
`identified in this section_
`
`I Remove I
`
`I Clear I
`
`Applicant ~
`
`• Assignee
`
`I
`
`Legal Representative under 35 U.S.C 117
`
`Joint Inventor
`
`I
`Person Who shows sufficient proprietary interest
`
`Person to whom the inventor is obligated to assign,
`
`I
`If applicant is the legal representative , indicate the authority to file the patent application, the inventor is:
`
`, ...
`
`I
`
`Name of the Deceased or Legally Incapacitated Inventor: I
`If the Applicant is an Organization check here.
`~
`I t',dvanced Aooelerator Applications (Italy) Sri
`Mailing Address Information For Applicant:
`
`Organization Name
`
`Address 1
`
`Address2
`
`City
`
`Country I IT
`
`Phone Number
`
`Via Ribes. 5
`
`::::.olleretto Giacosa
`
`State/Province
`
`Postal Code
`
`Fax Number
`
`10010
`
`Email Address
`
`pip _inbox.phchbs@novartis.com
`
`Additional Applicant Data may be generated within this form by selecting the Add button.
`
`I Add
`
`11
`
`Assignee Information including Non-Applicant Assignee Information:
`
`Providing assignment information in this section does not substitute for compliance with any requirement of part 3 ofTitle
`37 of CFR to have an assignment recorded by the Office.
`
`EFS Web 2.2.12
`
`Evergeen Ex. 1004
`9 of 324
`
`

`

`PTO/AWM (11-15)
`Approved for use through 04130/2017. 0MB 0651 ·0032
`U .S. Patent and Trademark Office; U.S , DEPARTMENT OF COMMERCE
`Under the Paperwork Redudion Act or 1995, no persons are required to respond lo a collec1ion of infO£TTiaoon unless it oontains a valid 0MB control number.
`
`Application Data Sheet 37 CFR 1. 76
`
`Attorney Docket Number
`
`PAT058197-US-CNT02
`
`Application Number
`
`Title of Invention
`
`Stable, concentrated radionuclide complex solutions
`
`Assignee ~
`
`Complete this section if assignee information, including non-applicant assignee infom1ation, is desired to be included on the patent
`application publicafion. An assignee-applicant identified in the "Applicant Information" section Will appear on the patent application
`publication as an applicanl For an assignee-applicant, tomplete this section only jf identification as an asslgnee is also desired on the
`patent application publication.
`
`If the Assignee or Non-Applicant Assignee is an Organization check here.
`
`I Remove I
`(cid:143)
`
`Suffix
`
`I
`
`B
`
`Prefix
`
`I
`
`Family Name
`I
`Mailing Address Information For Assignee including Non-Applicant Assignee:
`
`Given Name
`
`Middle Name
`
`lsr I
`
`I
`
`Address 1
`
`Address 2
`
`City
`
`Countryi
`
`11
`Phone Number
`
`11
`
`State/Province
`
`Postal Code
`
`Fax Number
`
`Email Address
`Additional Assignee or Non-Applicant Assignee Data may be generated within this form by
`selecting the Add button.
`
`I Add
`
`I
`
`Signature:
`NOTE; This Application Data Sh.eet must be signed in accordance with 37 CFR 1.33(b ). However, if this Application
`Data Sheet is submitted With the INITIAL filing of the application and either box A or B is not checked in
`subsection 2 of the "Authorization or Opt-Out of Authorization to Permit Access" section, then this fonn must
`also be signed in accordance with 37 CFR 1.14(c}.
`This Application Data Sheet must be signed by a patent practitioner if one or more of the applicants is a juristic
`entity (e.g., corporation or association). If the applicant is two or more joint inventors, this form must be signed by a
`patent practitioner, all joint inventors who are the applicant, or one or more joint inventor-applicants who have been given
`power of attomey (e.g., see USPTO Form PTO/AIA/81) on behalf of all joint inventor-applicants.
`See 37 CFR 1 .4(d) for the manner of m:3king signatures and certifications.
`
`Remove
`
`Signature
`
`/Lian Ouyang/
`
`Date (YYYY-MM-DD) ~o rn-10--30
`
`First Name
`
`~ian
`
`I Last Name I puyang
`
`Additional Signature may be generated within this form 'by selecting the Add button.
`
`Registration Number
`~9.254
`I Add
`I
`
`EFS Web 2.2.12
`
`Evergeen Ex. 1004
`10 of 324
`
`

`

`PTO/AW14 (11-15)
`Approved for use through 04130/2017. 0MB 0651 ·0032
`U .S . Patent and Trademark Office; U.S , DEPARTMENT OF COMMERCE
`Under the Paperwork Redudion Act of 1995, no persons are required to respond lo a collec1ion of infonnaoon unless it oonlains a vaud 0MB control number.
`
`Application Data Sheet 37 CFR 1. 76
`
`Attorney Docket Number
`
`PAT058197-US-CNT02
`
`,Application Number
`
`Title of Invention
`
`Stable, concentrated radionuclide complex solutions
`
`This collection of information is required by 37 CFR 1. 76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTO to process) an application Confidentiality is governed by 35 U.S C. 122 and 37 CFR 1 14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S Department of Commerce, P.O. Box 1450, Alexandria, VA 22313- 1450 DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS , SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.12
`
`Evergeen Ex. 1004
`11 of 324
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to a patent
`application or patent. Accordingly, pursuant to the requirements of the Act, please be ad\lised that (1 l the general authority for the collection of this information
`is 35 U5.C. 2(bl(2); (2) furnishing of the Information solfcited is voluntary; and (3) the principal purpose for which the information Is used by the U.S. Patent and
`Trademark Office isto proce55 and/or examine your submission related to a patent application or patent. If you do not furnish the requested information, the U.S.
`Patent and Trademark Office may not be able to process and/or examine your s1.1bmission, which may result in termination of proceedings 01 abandonment of
`the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses;
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552) and the Privacy
`Act (5 U5.C. 552a). Records from this system of records may be disclosed to the Department of Justice to determine whether the Freedom of
`Information Act requires disclosure of these records.
`
`2. A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or administrative
`tribunal, including di~losures to opposing counsel in the course of settlement negotiations.
`
`3
`
`A record in this system of recor1b may be disclosed, as a routine use, to a Member of Congress submitting a request involving an individual, to whom
`the record pertains, when the individllill has requested assistance from the Member with respect to the subject matter of the record.
`
`4. A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for the information in order to perform
`a contract Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as amended. pursuant to 5 U.S.C.
`552.a(m).
`
`5. A record related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed, as a routine use,
`to the International Bureau of the World Intellectual Property Organization, pursuantto the PatentCooperationTreaty.
`
`6, A record in this ~stem of records may be disclosed, as a routine use, to another federa l agency for purp